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Summary 
A key cytokine induced during the immune response 
is 11-2. Following T cell activation, the genes encoding 
IL-2 and ths varlouschains of lta receptor are transcrip 
tionally induced. In turn, secreted IL-2 serves to stimu- 
late the proliferation and dlfferentiatlon of T lympho- 
cytes. Several recent studies have implicated Jak 
kinases in the signallng pathway induced by IL-2. Fol- 
lowing this lead, we set out to identtfy tmnacrlption 
factors induced in response to 11-2. Human peripheral 
blood lymphocytes were observed to contain several 
IL-24nduclble DNA binding activities. Similar activities 
were also observed in a transformed human lympho- 
cyte line, termed YT. We have purlfied these activities 
and found that the principal IL-Plnducible component 
beam signlftcant relatedness to a prolactin-induced 
tmnscriptton factor flmt identtfled in sheep mammary 
gland tissue. We hypothesize that acttvatlon of this 
protein, deslgnated hStat5, helps govern the biologi- 
cal effects of IL-2 during the immune response. 
lntroductlon 
Acting through a high affinity multisubunit receptor, in- 
terleukin-2 (IL-2) stimulates the proliferation and differenti- 
ated function of hematopoietic cells (Taniguchi et al., 
1988; Smith, 1988; Taniguchi and Minami, 1993; Wald- 
mann, 1993). Considerable progress has been made dur- 
ing the past decade on the biological effects of IL-2 as 
well as the molecular composition of the cytokine and its 
cognate receptor. Cells bearing the functional receptor 
complex respond to IL-2 via at least two distinctive path- 
ways. Theycommonlyenter a proliferative state facilitating 
significant autocrine expansion. IL-2 can also cause re- 
ceptor-bearing lymphocytes to mature along variousdiffer- 
entiative pathways, including those leading to cytolytic and 
immune helper cell function. The intracellular signaling 
and gene regulatory circuitry controlled by IL-2 is, how- 
ever, only beginning to be resolved. Perhaps the most 
useful information pertaining to the latter challenge has 
come from studies of the IL-2 receptor. 
Functional IL-2 receptor is a heterotrimeric complex 
composed of polypeptide chains designated IL-2Ra, IL- 
2Rf3, and IL-2Rr (Cosman et al., 1984; Leonard et al., 
1984; Nikaido et al., 1984; Hatakeyama et al., 1989; 
Takeshita et al., 1992; Voss et al., 1993). The IL-2Ra chain 
appears to be uniquely dedicated to IL-2 response, 
whereas the ILQR8 and IL-2Ry chains are commonly used 
by other cytokine receptors (Kondo et al., 1993; Noguchi 
et al., 1993; Giri et al., 1994). On itsown, IL-2Ra is capable 
of low affinity binding to 11-2. High affinity binding and 
biological response to IL-2 requires, however, association 
of IL-2Ra with the IL-2R8 and IL-2Ry chainsof the receptor 
(Minamoto et al., 1990; Takeshitaet al., 1990). Moreover, 
functional signaling via the IL-2 receptor is dependent 
upon the integrity of the intracellular domains of IL-2R8 
and IL-2Rr (Kawahara et al., 1994; Nakamura et al., 1994; 
Nelson et al., 1994). 
Two lines of evidence have indicated that IL-2 may alter 
the program of gene expression in receptor-bearing cells 
via a pathway involving Janus kinases (Jaks) and signal 
transducers and activators of transcription (Stat). Upon 
stimulation by 11-2, receptor-bearing cells have been 
shown to activate the Jakl and Jak3 tyrosine kinases 
(Boussiotis et al., 1994; Miyazaki et al., 1994; Russell et 
al., 1994). IL-2 hasalso beenobserved toactivateanother- 
wise latent DNA binding activity bearing properties related 
to Stat proteins (Gilmour and Reich, 1994; Beadling et al., 
1994). In this study, we have purified and identified the 
transcription factors activated in human lymphocytes in 
response to IL-2. 
RMUltS 
Peripheral blood lymphocytes (PBLs) isolated from human 
plasma were cultured in the presence (hereafter desig- 
nated “stimulated”) or absence (hereafter designated ‘rest- 
ing”) of phytohemagglutinin (PHA) for 3 days. PHA-stimu- 
lated cells were washed and cultured for an additional 12 
hr in the absence of PHA. Both cultures were exposed to 
varying concentrations of recombinant IL-2 for 15 min, 
then used to prepare nuclear extracts (see Experimental 
Procedures). Gel mobility shift assays were performed us- 
ing a DNA probe derived from the promoter of the gene 
encoding the FcyRl immunoglobulin receptor that is 
known to bind Stat proteins avidly (Kotanides and Reich, 
1993). 
Nuclear extracts prepared from both PHAstimulated 
and resting PBLs contained three DNA binding activities 
capable of forming stable complexes with the FcyRl probe 
(Figures 1A and 1 B). The slowest migrating complex, des- 
ignated Pl, was eliminated when challenged with specific 
competitor DNA, yet was insensitive to competition by a 
mutated derivative of the FcyRl probe (see Experimental 
Procedures). The two more rapidly migrating complexes 
were insensitive to challenge with specific competitor DNA 
and therefore deemed nonspecific (NS). 
IL-2 treatment of both PHA-stimulated and resting PBL 
cultures failed to substantially alter the abundance of the 
activities responsible for generating either the Pl or NS 
complexes. Cytokine treatment did, however, lead to the 
appearance of a DNA binding activity, designated P2, that 
was sensitive to competition by the FcyRl probe (Figures 
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Figure 1. Gel Mobility Shift Assays Udng Nu- 
clear Extract8 Prepared from Resting and IL-2- 
Induced Human Lymphoqtes 
(Left) Results of gel shift assays using nuciear 
extracts prepared from resting PBLS exporxtd 
to varying wncenlratlons of recombinant 11-2. 
Protein-DNA complexes dedgnated NS were 
not selectively competed by the FcyRl probe. 
The PI and P2 complexes were sendttve to 
speciRcwmpetitorbuti~naitivetoamutated 
derivative of the FcyRl probe (see Experimen- 
tal Procedures). The Pl complex was obeewed 
irrespective of IL-2 stimulation. The P2 corn- 
plex was maximally induced in reqonse to in- 
termediate concentrations (lo-30 *ml) of 
11-2. 
(Middle) Get shift results using nuclear extracts 
prepared from PHA-stfmulated PBLS. The pat- 
tern of NS, Pl , and P2 complexes mrcl similar 
to that observed from resting PBLs, except for 
the sensitivity of P2 formation to lower concentrations of IL-2 substantially. (Right) Results of gel shift assays using nudear extract8 prepared from 
YT cells. Protein-DNA complexes designated NS were not selectively competed by the FcyRl probe. The Y 1, Y2, and Y3 complexes were wnsitlve 
to specific competitor but insensitive to the mutated FcrRl probe. The Yl complex was formed with nuclear extracts from unstimulated YT cells, 
whereas the Y2 and Y3 complexes were induced, respectively, at intermediate and high concentrations of IL-2 
1 A and 1 B). Optimal activation of the P2 complex in resting 
PBLs required 30 rig/ml of 11-2. PHA-stimulated PBLscon- 
tained peak levels of this activity when stimulated at the 
lowest dose of IL-2 tested (3 @ml). 
A transformed human lymphocyte cell line, termed YT 
(Yodoi et al., 1985) was identified as a potential source for 
purification of IL-2-induced transcription factors. Nuclear 
extracts prepared from uninduced YT cells were observed 
to contain several activities capable of binding to the FcyRl 
probe (Figure 1 C). Competition assays revealed .t& stow- 
est migrating complex c/l) to be specific and th6 more 
rapidly migrating complexes to be NS. None of the three 
activities appeared to change as a function of IL-2 presen- 
tation. Following exposure for 15 minto recombinant 11-2, 
however, two new DNA binding activities were obsewed. 
One activity, designated Y2, was induced in response to 
intermediate concentrations of IL-2 (10-30 rig/ml). The 
other, designated Y3, required exposure to higher concen- 
tration of cytokine(30-100 @ml). Both of the IL-Binduced 
DNA binding activities obtained from YT cells were sensi- 
tive to specific competitor DNA, yet insensitive to the mu- 
tated derivative of the FcyRl probe. 
Two observations indicated that the constitutive (Pl) 
and IL-2-induced (P2) complexes obtained from PBLs 
might correspond, respectively, to the IL-e-induced com- 
plexes obtained from YT cells (Y2 and Y3). First, they 
comtgrated when analyzed by the gel mobility shift assay 
(Pl = Y3 and P2 = Y2). Second, the P2 and Y2 complexes 
were induced in resting PBLs and YT cells with similar 
dose dependencies (10-30 nglml). 
Having obtained provisional evidence that PBLs and YT 
cells induce similar DNA binding activities in response to 
11-2, we set out to purify the polypeptides specifying these 
activities. Nuclear extracts were prepared from 40 I of YT 
cells that had been exposed for 15 min to 30 nglml of 
recombinant 11-2. A purification scheme involving ammo- 
nium sulfate precipitation followed by S-Sepharose, DNA 
affinity, and Q-Sepharose chromatography (see Experi- 
mental Procedures) led to the isolation of a complex group 
of polypeptides that migrated on denaturing potyacryl- 
amide gels in the range of 88-100 kDa. Western blotting 
assays, using anti-phosphotyrosine antibodies gave evi- 
” dentie that many, if not all, of these proteins were tyrosine 
phosphorylated, 
The proteins purified according to procedures outlined 
’ 
in,the precedhg paragraph werecleaved wjth tysine C and 
resulting peptide fragments were fractionated by reverse 
ph~,caMary high performance liquid chromatography 
(HPLC). .Partiat amino acid sequences were resotved for 
six peptides (see Experimental Procedures). When com- 
pared with a data base of known protein sequences, two 
of the sequenced peptides were found to correspond to 
Stat1 (Schindler et al., 1992) and four to Stat3 (Akira et 
al., 1994). 
Apparently, YT cells induced with IL-2 contain activated 
Stat1 and Stat3. Recall, however, that at least three dis- 
tinct Stat-like complexes were observed in YT nuclear ex- 
tracts. One such complex, termed Yl, was present irre- 
spective of IL-2 presentation. The other two, designated 
Y2 and Y3, were induced, respectively, by intermediate 
and relatively high levels of recombinant 11-2. 
To determine the molecular identities of the three com- 
plexes, antibodies specific to Stat1 and Stat3 were incu- 
bated with nuclear extracts derived from uninduced and 
IL-Pinduced YT cells. As shown in Figure 2, antibodies 
specific to Stat1 did not affect the Yl complex formed 
between uninduced YT nuclear extract and the FoyRl 
probe. However, when incubated with extracts prepared 
from cells exposed to 30 @ml 11-2, the Stat1 antibody 
altered the mobility of the most rapidly migrating IL-2- 
induced complex (Y3). Compared with untreated extracts, 
or extracts incubated with control antibodies, those incu- 
bated with antibodies to Stat1 resulted in a protein-DNA 
complex that migrated at a significantly retarded (super- 
Purification of IL-24nduced Stat Proteins 
323 
f Y 
B 
2 -f 2 p! T z 
3 3 3 5 I 3 
2 2 2 f B 3 si % % 
ou4444 ou44440 
Yl Yl 
Y2 P2 
Y3 Pl 
IL-2 Induced 
IL-2 
Induced 
PBLs 
shifted) rate. identical results were observed with nuclear 
extracts prepared from PBLs induced with 30 rig/ml of 
IL-2. That is, the Pl complex was selectively supershifted 
by Stat1 antibodies. We therefore conclude that Stat1 was 
activated in YT cells in response to relatively high concen- 
trations of 11-2. PBLs also contain Stat1 that, at least in 
the case of the PHA stimulation, was marginally induced 
by IL-2. 
Antibodies to Stat3 were also tested using nuclear ex- 
tracts prepared from uninduced YT cells, as well’as YT 
cells and PBLs that had been exposed for 15 min to 30 
rig/ml IL-2(Figure2). In thiscase, weobsetvedadistinctive 
alteration in the migration of the Yl complex formed by 
YT nuclear extracts, irrespective of exposure to IL-2. Anti- 
bodies to Stat3 did not affect the abundance or migration 
of DNA binding activities derived from IL-2-induced PBLs, 
irrespective of stimulation by PHA. According to these ob 
servations, we conclude that active Stat3 is constitutlvely 
present in YT cells and is not further stimulated by IL-2 
in either YT cells or PBLs. 
The observations outlined thus far provide a molecular 
link between Stat1 and a protein-DNA complex induced 
Proteins capable of high affinity binding to the 
FcyFtl probe were purfffed (see Experimental 
Procedures) and subjected to immunodepie 
tion using antibodies to Stat1 and Stat3 wu- 
pled to protein A-Sepharose. Load (L), Raw- 
through (Ff), wash ON), and bound (B) protein 
fractions were eiectrophoresed on four SDS- 
polyacryalmide gels and transferred to PVDF 
Coomassie Anti pTYR Stat-l Ab 
Stain Blot Blot 
membranes. One membrane (left) was stained 
with Coomassie blue and the remalnlng three 
were stained with antisera specific to phospho 
tyrosine (second from left), Stat1 (second from right), and Stat3 (right). Note that despite effective removal of Stat1 and Stat3, unbound fraction 
retained potypeptides migrating with apparent masses of 85-100 kDa that reacted strongly with anti-phosphotyrosine antibodies. 
Figure 2. Molecular Identification of Polypep 
tides involved in DNA-Protein Complexes De- 
rived from Human Lymphocytes 
YT nuclear extracts were prepared from either 
unstimulated cells (left) or cells that had been 
exposed to 30 ng/mi of IL-2 (right). Prior to for- 
mation of protein-DNA complexes, nuclear ex- 
tracts were incubated with antibodies to known 
Stat proteins. Antibodles to Stat3 supershifted 
the Yl complex formed by YT nuclear extracts 
irrespective of IL-2 treatment, indicating the 
constttutive presence of active Btat3. Antibod- 
ies to Stat1 supershifted the Y3 complex 
formed by YT nuclear extracts fotfowing treat- 
ment with high levels of IL-2 (see Figure 1). The 
right lane of the right panel shows protein-DNA 
complexes formed by nuclear extracts of rest- 
ing PBLs following induction by 30 n@ml of 
IL-2. The more rapidly migrating complex (Pl) 
comigrated with the Y3 complex that reacted 
with antibodies to Statl. Antibody supershift 
assays using PBL nuclear extracts showed that 
the Pl complex corresponds to Stat1 (data not 
shown). 
in YT cells by relatively high levels of IL-2 (designated Y3), 
as well as a link between Stat3 and a complex present 
in uninduced YT cells (designated Yl). Left unresolved, 
however, was the molecular nature of the Y2 activity in- 
duced in YT cetls by intermediate concentrations of 11-2. 
A comigrating DNA-protein complex, designated P2, was 
also induced by intermediate concentrations of IL-2 in rest- 
ing PBLs, and by very low concentrations of IL-2 in PHA- 
stimulated PBLs. To resolve the identity of the polypep 
tides specifying this activity, the complex of Stat proteins 
purified from YT cells was purged of Stat1 and Stat3 by 
immunodepletion. 
Protein purified from 20 I of IL-Binduced YT cells was 
incubated sequentially with antibodies specific to Stat1 
and Stat3 and Sepharose beads linked to protein A (see 
Experimental Procedures). Load, flow-through, wash, and 
bound fractions were then analyzed by SDS-gel electro- 
phoresis and subsequent staining using Coomassie blue 
as well as antibodies to phosphotyrosine, Stat1 and Stat3. 
The resulting staining patterns (Figure 3) revealed effec- 
tive depletion of Stat1 and Stat3. Both Coomassie and 
anti-phosphotyrosine staining indicated, however, that the 
Figure 3. Immunodepfetion of Stat1 and Stat3 
from Stat-Like Proteins Purtfied from IL-2- 
Induced YT Cells 
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Figure 4. MALDI Mass Spectrometry Analysis of a Tyrosine-Contatn- 
ing Peptide Derived from an IL-2-Induced Stat Protein 
Large panel shows reversed phase capillary HPLC profile of lysine 
C peptides digested from the 96 kDa Stat-like protein purfffed from 
IL-2induced YT cells and purged of Stat1 and Stat3 (see Figure 3). 
Peak 12, which eluted at 41 min, yielded the sequence NH*AVDGXV- 
KWIK-CCCH. MALDI mass spectrometry analysis of peak 12 yielded 
a mass of 1.297.0 daltons. The predicted mass of the peptide, ff X - 
phosphotyrosine, is 1299.4 daltons. A perfect match to this sequence 
(NHp-AVWYVKPQIK-CCDH) was found in the conceptually trans- 
lated sequence of the hStat3 cDNA clone (Figure 6). 
flow through fraction retained Stat-like proteins. The three 
most prominent polypeptides remaining following immu- 
nodepletion were excised and individually digested with 
lysine C. Resulting peptide fragments were separated by 
reverse phase capillary HPLC and subjected to partial 
amino acid sequence analysis. 
The largest of the three polypeptide bands, which mi- 
grated with an apparent molecular massof 98 kDa, yielded 
three peptide sequences, all of which matched the se- 
quence of a previously characterized protein variously 
termed mammary gland factor (MGF) or Stat5 (Wakao et 
al., 1994). Two of the peptides yielded unambiguous se- 
quences of 10 and 14 residues. Both of these sequences 
were identical to segments of MGF/Stat5 (see Figure 6). 
The third peptide, designated peak 12 (Figure 4), did not 
contain an identifiable amino acid residue in the fifth Ed- 
man degradation cycle. Cf the 11 residues of this se- 
quence, 10 did, however, match perfectly with a segment 
located close to the carboxyl terminus of fvlGFIStat5. The 
unidentified residue of this peptide corresponded to tyro- 
sine residue 694 of MGF/Stat5, which has been identified 
as the substrate for Jak-mediated phosphorylation (Gouil- 
leux et al., 1994). 
Reasoning that the ambiguity observed upon amino acid 
sequence analysis of this third peptide might reflect the 
fact the fifth residue was phosphorylated on tyrosine, and 
therefore not extracted by the nonpolar solvent used to 
extract the phenylthiohydantion during Edman degrada- 
tion (Aebersold et al., 1991) we performed matrix-assisted 
laser ionization desorptionlionization (MALDI) mass spec- 
trometty analysis (Figure 4). The observed mass of the 
peptide (1,297.O f 2 daltons) corresponded very closely 
to that predicted for the tyrosine phosphoform of the se- 
quence NHrAVDGYVKPQIK-CCCH (1,298.4). Given 
that the affinity chromatographic step of our purification 
procedure selects for the active form of Stat proteins (Hou 
et al., 1994) and that the Stat activation cycle entails tyro- 
sine phosphorylation (Darnell et al., lQQ4), it is not surpris- 
ing that the Stat protein activated in IL-2-induced YT cells 
is tyrosine phosphorylated. 
Peptide sequence analysis of two smaller Stat-like pro- 
teins remaining after immunodepletion (migrating with ap- 
parent masses of 94 and 88 kDa) also yielded sequences 
identical to MGFIStat5. In both cases, peptides bearing the 
ambiguous sequence NHrAVDGXVKPQIK-CCCH were 
also observed. We thus conclude that the sample of pro- 
teins purified from IL-8induced YT cells, following deple- 
tion of Stat1 and Stat8 is largely composed of polypeptides 
related to MGF/Stat5. Moreover, the three predominant 
species (98, 94, and 88 kDa) all appear to be tyrosine 
phosphorylated on the same residue. We tentatively con- 
clude that activation of this family of proteins by IL-2 in 
human YT cells entails tyrosine phosphorylation at the 
same position as prolactin-mediated activation of MGF/ 
Stat5 (Gouilleux et al., 1994). 
Having established a molecular link between Stat5 and 
the DNA binding activity induced by IL-2 in YT cells (desig- 
nated Y2), we set out to determine the identity of the DNA 
binding activity induced by IL-2 in PBLs. Whereas the ac- 
tivity induced by IL-2 in both resting and PHA-stimulated 
PBLs (designated P2) comigrated on nondenaturing gels 
with that induced in YT cells c/2), we did not have antibod- 
ies that would allow rigorous testing of the identity of the 
Stat protein induced in PBLs. As such, we purified the 
activity to obtain partial amino acid sequence of the rele- 
vant polypeptides. 
Lymphocytes were isolated from 10 U of human blood 
and grown for 3 days in the presence of PHA. The cells 
were then washed, cultured for 12 hr in the absence of 
PHA, exposed for 15 min to 10 @ml of 11-2, harvested, 
and used to prepare nuclear extracts. The IL-2-induced 
DNA binding activity was purified by the same method 
used to isolate Stat proteins from YTcells(see Experimen- 
tal Procedures). 
As shown in Figure 5, these procedures led to the purifi- 
cation of two polypeptides that migrated with apparent 
molecular masses of 96 and 95 kDa. Western blot assays 
provided evidence that both of these polypeptides reacted 
strongly with antibodies to phosphotyrosine. Each poly- 
peptide was excised, digested with lysine C, and the re- 
sulting peptide fragments were fractionated by capillary 
HPLC. The two proteins yielded very similar lysine C di- 
gests as assessed by the UV spectral traces of the re- 
sulting chromatograms. Mass spectrometry analysis of in- 
dividual coeluting peptides provided additional evidence 
of a close relatedness between the 96 and 95 kDa polypep- 
tides. Two peptides were subjected to gas phase sequenc- 
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Flgure 5. Purification of Stat-Like Proteins from IL-24nduced PBLs 
PHA4mulated PBLs were exposed to 10 rig/ml IL-2 and used to 
;&with the FoyRl probe were purified (see Experimental Procedures), 
subjected to SDS-gel electrophoresis, transferred onto a PVDF mem- 
brane, and stained with antiphosphotyrosine antibodies. Following 
development of the Western blot (right), the filter was stained with 
Coomassie blue (left). Two prominent phosphotyroslne-containing 
polypeptides were obsenred to migrate with apparent molecular 
masses of 90 and 55 kDa. Partial amino acid sequencing of both poly- 
peptides revealed multiple fragments bearing sequences identical to 
hStat5 (see Figure 6). 
ing, yielding sequences highly related to MGF/&at5 (see 
Figure 6). We thus conclude that the predominant Stat 
protein induced by IL-2 in PI-IA-stimulated human lympho- 
cytes is highly related to MGF/StatS. 
AcDNAclone corresponding to the human form of Stat5 
was isolated and sequenced (Figure 6). Conceptual trans- 
lation of the DNA sequence specified an open reading 
frame (ORF) of 794 aa residues which, in an unmodified 
state, predicts a molecular mass of 90,544 daltons. Seg- 
ments identical to all three of the peptides derived from 
the IL-2-induced protein from YT cells (Y2) and two of the 
peptides derived from the IL-2-induced protein from PBLs 
(P2) were observed in the ORF. The third peptide se- 
quence derived from the IL-2-induced protein purified from 
PSLs matched the ORF at 5 consecutive residues, yet 
diverged significantly at amino acid residue 667. We spec- 
ulate that this may represent the result of alternative splic- 
ing or presence of a second highly related hStat5 gene. 
Additional studies will be required to resolve between 
these alternative hypotheses. 
Figure 6 compares the sequence of the cloned gene 
product, hereby designated human Stat5 (hStat5), and the 
previously characterized MGF protein of sheep (Wakao 
et al., 1994). Whether the two proteins represent molecular 
Figure 6. DNA Sequence Comparison Between hStatS and MGF 
A recombinant clone encoding hStat5 was isolated from a cDNA library 
prepared with mRNA from human umbilical vein endothelial cells. DNA 
sequence was resolved on both DNA strands by the chain termination 
method of DNA sequencing. Conceptually translated amino acid se- 
quences of hStat5 (top) and MGF (bottom) are compared (Wakao et al., 
1994). Dverlined segments correspond to peptides sequenced from 
protein purified from IL-Binduced YT cells (Yr 22, YT 21, and Yl 
12) and IL-Iinduced PBLs (PBL 12 and PBL-MB). The hStat5 ORF 
consistsof 794aa that, inanunmodifiedstate, specifiesthemonomeric 
size of 90.5 kDa. Abbreviations for the amino acid residues are the 
following: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; 0, Gly; H, His; I, Ile; 
K, Lys; L. Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; 
V, Val; W, Trp; and Y, Tyr. 
counterparts can not be conclusively established at pres- 
ent. Although significant segments of amino acid se- 
quence identity occur throughout the two proteins, three 
divergent regions were observed (residues 90-107,260- 
272, and 717-COOH). As such, it is possible that the 
sheep and human proteins are encoded by two distinct 
genetic loci. 
The tissue distribution of hStat5 gene expression was 
examined by Northern blotting as shown in Figure 7. Mes- 
senger RNAs of measuring roughly 3,4, and 6 kb in length 
were observed. The larger two mRNAs were observed in 
all human tissues that were examined, with roughlyequiv- 
alent levelsoccurring in placenta, skeletal muscle, spleen, 
thymus, prostate, testis, ovary, small intestine, colon, and 
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Figure 7. Tissue Distribution of hStat5 Messenger RNA 
Nylon membranes containing polyadenylated-enriched mRNA from 
16 human tissues were probed by nucleic acid hybridization at high 
stringency for hStat5 mRNA. Two prominent bands roughly 4 and 6 
kb in length were observed in most tissues. A smaller band, approxi- 
mately 3 kb in length, was observed in placenta, skeletal muscle, and 
kidney. 
PBLs; slightly lower levels in heart, lung, kidney, and pan- 
creas; and considerably lover levels in brain and liver. The 
small (3 kb) mRNA was observed in a more restricted pat- 
tern, limited to placenta, skeletal muscle, and testis. It is 
unclear whether these various hStat5 mRNAs are ex- 
pressed as differentially processed products of a single 
gene or the transcribed products of distinct genes. 
Here we report the purification and molecular identification 
of transcription factors activated in human lymphocytes 
in response to 11-2. Our studies have made use of a trans- 
formed natural killer-like cell line, termed YT (Yodoi et 
al., 1985) as well as resting and PHA-stimulated PBLs. 
Uninduced YT cells were obsenred to contain a Stat-like 
DNA binding activity that, upon purification and molecular 
characterization, was identified as the human form of 
Stat3. Previous studies have identified Stat3 as a tran- 
scription factor rapidly activated by IL-8 (Akira et al., 1994). 
We hypothesize that cultured YT cells secrete an auto- 
crine activity responsible for the constitutive presence of 
activated Stat3 Treatment of YT cells with IL-2 did not 
appear to influence the abundance of activated Stats. 
Likewise, IL-2 did not lead to the induction of Stat3 in either 
resting or PHA-stimulated PBLs. 
One prominent Stat-like activity was observed to be in- 
duced by IL-2 in all of the cell cultures hereby examined. 
This activity, designated Y2 in YT cells and P2 in resting 
and PHA-stimulated PBLs, was identified as hStat5, a hu- 
man protein bearing significant similarity to MGF of sheep 
(Wakao et al., 1994). Optimal induction of hStat5 in YT 
cells and resting PBLs required 19-30 @ml of 11-2. Acti- 
vation of hStat5 in PHA-stimulated PBLs required no more 
than 3 nglml cytokine. Whereas we have not resolved the 
molecular basis for this observed change in sensitivity to 
IL-2, it may result from an increase in the concentration 
of one or more of the subunits constituting the high affinity 
IL-2 receptor. 
Several observations made in this study give evidence 
of heterogeneous forms of hStat5. First, regardless of 
whether purified from YT cells or PHA-stimulated PBLs, 
hStat5 consisted of multiple polypeptides. Second, North- 
ern blot assays of mRNA prepared from a variety of human 
tissues revealed three distinct hStat5 transcripts. Finally, 
amino acid sequence analysis of the 95 kDa polypeptide 
purified from IL-2-stimulated PBLs revealed a peptide that 
matched the conceptually translated hStat5 sequence 
over 5 residues, yet diverged significantly over the contigu- 
ous 7 residues. It may be important that the location of 
this divergence is 8 residues upstream from the identified 
site of tyrosine phosphorylation. If correct, the sequence 
of this peptide predicts the presence of hStat5 variants 
that may be tyrosine phosphotylated in different ways. The 
origin of this variation may reflect differential splicing of 
transcripts encoded by a single hStat5 gene, or the pres- 
ence of more than one encoding gene. 
A second Stat-like activity was induced in two of the 
three cell types. This activity, designated Y3 in YT cells 
and Pl in resting and PHA-stimulated PBLs, was identified 
as the human form of Statl. Induction of Stat1 in YT cells 
required very high concentrations of 11-2. Low concentra- 
tions of IL-2 resulted in a modest induction of Stat1 in 
PHA-stimulated PBLs. Finally, resting PBLs failed to in- 
duce Stat1 substantially in response to 11-2. 
Partial amino acid sequence of the Stat protein (hStat5) 
activated at the lowest concentration of IL-2 provided indi- 
rect evidence of tyrosine phosphorylation at residue 894. 
Edman degradation of the peptide bearing this tyrosine 
failed to yield an amino acid at the expected cycle. If this 
tyrosine residue was quantitatively phosphorylated, it 
would not be expected to be extracted by the nonpolar 
solvents used for amino acid sequence analysis (Aeber- 
sold et al., 1991). Additionally, mass spectromettyanalysis 
of the relevant peptide yielded a mass consistent with the 
tyrosine phosphoform (Yip and Hutchens, 1992). On the 
basis of these observations, we conclude that IL-2 activa- 
tion of hStat5 entails tyrosine phosphorylation at precisely 
the same position as prolactin-mediated activation of MGF 
(Gouilleux et al., 1994). 
The relevance of the aforementioned finding may be 
signified by the fact that prolactin and IL-2 activate differ- 
ent Jak kinases. Two recent studies have provided evi- 
dence that prolactin activates Jak2 (Gilmour and Reich, 
1994; Rui et al., 1994). In contrast, IL-2 has been shown 
to activate Jakl and Jakd (Boussiotis et al., 1994; Johns- 
ton et al., 1994; Miyazaki et al., 1994; Russell et al., 1994; 
Witthuhn et al., 1994). Having found that MGF and hStat5 
are tyrosine phosphorylated on the same residue (894), 
we provisionally conclude that the specificity of activation 
is not controlled by Jak kinases. We instead believe that 
the functional Jak employed in Stat activation is dictated 
by the intracellular domain of the relevant receptor. In the 
case of the prolactin receptor, MGF activation is mediated 
by Jak2, owing, presumably, to the affinity of Jak2 to the 
intracellular domain of the prolactin receptor. In contrast, 
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hStat5 is activated by Jakl , Jak3, or both by virtue of their 
affinity to one or more chains of the IL-2 receptor. Taken 
most literally, this interpretation predicts that specificity of 
Stat activation rests on coupling of the latent transcription 
factor to the intracellular domain of its cognate receptor 
(Greenlund et al., 1994; Hou et al., 1994). If so, the decod- 
ing of this hypothetical network of receptor coupling repre- 
sents a critical and central objective for the field. 
The observations reported herein raise several im- 
portant questions. First and foremost, how is it that IL-2 
is able to coordinate a selective biological response by 
activating transcription factors that are subject to regula- 
tion by physiologically distinct cytokines and growth fac- 
tors? Firm evidence has demonstrated activation of Stat1 
by cytokines, such as interferon y, as well as growth fac- 
tors, such as epidermal growth factor, that are biologically 
distinct from IL-2. Likewise, MGF, the putativesheepcoun- 
terpart of hStat5, is activated by aseeminglydistinctstimu- 
lant (prolactin) from 11-2. If different cytokines and growth 
factors activate overlapping or identical Stat proteins, how 
are biologically distinct patterns of response generated? 
It is possible that the concentration of IL-2 required for 
activation of Stat1 (30-l 00 rig/ml in Yl cells) is not physio- 
logically relevant, and that Stat1 does not play a significant 
role in mediating the biological effects of 11-2. Given that 
hStat5 is activated at substantially lower cytokine concen- 
trations, we judge it to be a more likely candidate for trans- 
mitting the effects of 11-2. In this regard, it is intriguing 
that prolactin and IL-2 do share the capacity to stimulate 
proliferation of T lymphocytes (Kelly et al., 1991). Thus, 
although at an organismal level IL-2 and prolactin coordi- 
nate largely distinct functions, they may act through a com- 
mon molecular pathway in T lymphocytes by activating 
hStat5. Indeed, Gilmour and Reich (1994) have provided 
evidence that prolactin and IL-2 induce an indistinguish- 
able DNA binding activity in a rat T lymphoma cell line 
termed Nb2. 
Asecond issue left unresolved by the present studycon- 
terns possible linkage between the various chains of the 
IL-2 receptor and the Stat proteins activated in response 
to ligand. IL-2 has been shown to activate Jakl and Jak3 
(Boussiotis et al., 1994; Johnston et al., 1994; Miyazaki 
et al., 1994; Russell et al., 1994; Witthuhn et al., 1994). 
Since it has been firmly established that Jak kinases play 
a central and direct role in Stat activation (Darnell et al., 
1994), one might anticipate transient association of IL-2- 
induced Stat proteins with one or more components of the 
IL-2 receptor. Studies relevant to this issue have provided 
evidence that Stat1 may transiently couple to a phospho- 
tyrosine located within the intracellular domain of the inter- 
feron)r receptor at an early point in its activation cycle 
(Greenlund et al., 1994). Similar interpretations have been 
concluded from studies of IL4mediated Stat activation 
(Hou et al., 1994). If receptor coupling proves to a broadly 
utilized step in the Stat activation cycle, it is predictable 
that a docking site for hStat5 will be discovered within the 
intracellular domain of one or more of the IL-2 receptor 
subunits. We have preliminarily observed that two tyro- 
sine-phosphorylated peptides derived from the C-terminal 
domain of the IL-2Rfl receptor chain are capable of inhib- 
iting the DNA binding activity of hStat5 (J. H. and S. L. M., 
unpublished data). Such observations, coupled with re- 
cent data showing that mutated derivatives of the IL-2Rfi 
receptor chain lacking the two most C-terminal tyrosine 
residues fail to activate hStat5 (H. Fujii, Y. Nakagawa, 
U. S,, A. Kawahara, F. Gouilleux, B. Groner, J. N. Ihle, 
Y. Minami, T. Miyazaki, and T. Taniguchi, personal com- 
munication), are indeed consistent with the direct receptor 
coupling model that has emerged from studies of inter- 
feron- (Greenlund et al., 1994) and IL4 (Hou et al., 1994). 
cell cultum 
The transformed human lymphocyte cell line Yl (Yodoi et al., 1955) 
was grown in RPM1 1640 culture medium supplemerIted with 10% 
fetal bovineserum, 1OmM HEPES(pH7.2), IOuM &memapWthanol, 
2 mM Lglutamine, 100 &ml streptomycin, and 100 &ml ampicillin. 
Cells grown to a density of 7 x 1OVml In T-150 flasks ware exposed 
to recombinant IL-2 (Bbaource International) for 15 min at 37OC, har- 
vested by centrifugatkn, and ueed to prepare nuclear extracts (Dip 
nam et al., 1983). PBLe obtained from Irvin Memorial Blood Bank (Ban 
Francisco, California) were harvested by centrifugatkn, resuspended 
inphosphatebufferedsaline,andappliiabpLymphoprep(Nycomed 
AS) in 50 ml conical centrifuge tubes. Following oentrifugatbn, the 
lymphocyte layer was retrieved, washed, and resuspended in the same 
culture medium used for Qlowth of Yl cells. Ceils were grown either 
in the presence or absence of Phaseolus vulgaria lectln (PHA) (Slgma) 
for 3 days. PHA-stimulated cells were rmehed, resuspended in culture 
medium lacking PHA, and grown for 12 hr. IL-2 treatment and prepara- 
tion of nuclear extracts was the same 88 used for YT cells. 
PurWketlon cl IL-?-Induced lr~scriptlon Factora 
Nuclear extracts from M cells (1 Q) and Pals (025 Q) were precipitated 
with 30% ammonium sulfate. The proteins were then removed by 
centrifugatkn and the supematant was then treated with so96 ammo- 
nium sulfate. Proteins precipitating between 30%-50% ammonium 
sulfate were recovered by centrifugatkn, resuspended in 20 mM 
HEPES(pH 7.9). 25% (v/v)Qlycerol, 0.1 M NaCI, 1.5 mM MQCI,, 0.2 mM 
EDTA, 0.5 mM phenylmethyisulfonate, 0.5 mM dithlothreitol (DlT), 1 
&ml aprotinin, 1 pglml pepsWin, 1 p@ml leupeptin, 1 mM beruami- 
dine, 1 mM sodium vanadate, 1 mM NaF, 5 mM Bglycerolphosphate 
(buffer C), and dialyzed against buffer C supplemented with NaCl to 
a final concentration of 150 mM. 
After dialysis, Insoluble proteins were removed by centrifugatkn 
and the remaining material was chromatographed over a 100 ml 
S-Sephamse (Phafmacia) column. Protein flow-through was mixed 
with a DNA-affinity resin prepared by coupling synthetic, biotinyiated 
DNA COm3pOndinQ to the IL4 response element of the gene encoding 
FcyRl (5cOTAllTCCCAGAAAAGGAAC-3~ to streptavidin agarose 
(Sigma). After binding (2 hr at 4OC), the affinity matrix w&8 placed on 
a disposable column and washed sequentially with IO ml of buffer C, 4 
mlofbufferCsupplementedwithamutatedvariantofthelL-4response 
element (5MTATCACCAGTCMGGAAC-3’) at 0.2 mglml, and 10 ml 
of buffer C. Protein was eluted by exposure to buffer C supplemented 
with 0.35 M NaCI, dialyzed against buffer C, and placed on a 0.5 ml 
C?-Sepharose (Pharmacia) coiumn. The mlumn ~88 washed with 5 
ml of buffer C and protein was eluded with 1 ml of buffer C suppie- 
mented with 0.35 M NaCI. 
Partlrl Amlno Acid Sequencing ol IL-2-induced 
Transcrlptlon Facton 
Purified IL-2induced DNA binding proteins were subjected to SDS- 
gel electmphoresis and transferred to a polyvinylidene dlfiuoride mem- 
brane (Mlllipore). The membrane was stained wllh Coomaasie blue 
R-250 in 40% methanol and 0.1% acetic acid for 30 8, then destained 
for 5 min with 10% acetic acid in 50% methanol. Relevant polypeptides 
were excised from the membrane and alkyiated with laopropylaceta- 
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mide (Krutzsch and Inman, 1993; Henzel et al., 1994) and then di- 
gested in 50 ui of 0.1 M ammonium bicarbonate. 10% acetonitrile with 
0.2 Bg of lysine C (Wake) at 37OC for 17 hr. The solution was then 
concentrated to 20 ul and directly injected onto a capillary high perfor- 
mance llquid chromatogram. The HPLC consisted of a prototype capil- 
lary gradient HPLC system (Waters Asecciates) and a model 783 UV 
detector equipped wkh a Z-shaped flow cell (LC Packings, Incorpo- 
rated). A 38 cm length of 0.025 mm inner dimension glass capillary 
was connected to the outlet of the Z-shaped cell Inside the detector 
housing to minimize the delay volume. The total delay volume was 
0.45 pl, which corresponded to a delay of 8 8 for a flow rate of 3.5 pl/ 
min. The short delay greatly facilitated hand collection of individual 
pepttda peaks. Peptktes were separated on a Cl8 capillary column 
(0.32 by 100 mm) (LC Packings, Incorporated) developed with 0.1% 
aqueoustrifloraceticacid as bufferA and acetonitrilecontaining0.07% 
trifluoroacettc acid as buffer B. Isolated peptides were sequenced on 
a 490 Applied Biosystems sequencer. Residual peptldes retained on 
the PVDF membrane were ale0 subjected to Edman sequencing. In 
the case of hStat5 purlfted from PHA-stimulated PBLs, this provided 
partial amino acid sequence of a very large lyslne C peptide, desig 
nated PBL-membrane bound (MB) collnearwith the C terminus of the 
intact hStat5 pmteln. The same sequence was found for this peptide 
regardlessofwhetherkwasderlvedfromthe98or95 kDapolypeptides 
(sea Figure 5). Sequence interpretation was performed on a DEC 5900 
computer (Henzel et al., 1887). 
Immuncdeptetlon, Sumlftlng, and Otlgonucleotlde 
Competltlon Assays 
Protein-DNA complexes were visualized by a gel mobility shift assay 
under nondenaturing conditions. Speciftclty of protein-DNA interao 
tion was tested using 1 OO-fold molar excess of ekher the native FcrRl 
probe (S’-GTAllTCCCAG~GGAAC-3’) or the mutated derivative 
(5’-GTATCACCCAGTCAAGGAAC-3’). Antibody supershift experi- 
ments were performed by incubating protein samples wlth antibodies 
(Santa Crur Btech) for 30 mln at 4OC prior to exposure to the FcrRl 
DNA probe. Proteins purified from M cells were purged of Stat1 and 
Stat3 byimmunodepletlon. Ctf each antibody, 500 pg (specific to Stat1 
and Stat3) was incubated for 2 hr at room temperature with a slurry 
of protein A-Sephaross beads (Pharmacia) sufficient to yield 109 ul 
of bed volume. Beads were washed three times with 1 ml of buffer C 
and then incubated for 2 hr at room temperature with Stat proteins 
purified from IL-2induced YT cells. Beads were recovered by centrifu- 
gation and washed three times with 1 ml of buffer C. Unbound, wash, 
and bound fractions were recovered and subjected to SDS-gel electro- 
phoresis for subsequent staining with Ccomassle blue, anti-phospho- 
tyrosine antibodies, and Stat antibodies. 
~a55 s-try 
Aliquots (0.2 ul) of the capillary HPLC-purified lysine C peptides were 
mixed on the sample probe Up with 0.2 pl of aoyano4hydroxycin- 
namic acid (saturated In 50% acetonltrile 2% trifluoroacetic acid). 
MALDI mass spectra were obtained with a Vestec (Houston, Texas) 
LaserTec Research laser desorption linear time-of-flash mass spec- 
trometer equipped with a 337 nm VSL-337 ND nitrogen laser (Laser 
Sciences, Incorporated). 
Clolllng of hStat5 CDNA 
A cDNA library prepared from human umbilical vein endothelial cells 
was probed at low stringency wtth a fragment of the IL-4 Stat cDNA 
(Hou et al., 1994) corresponding to the SH3 and SH2 domains of the 
protein. Radiolabeled probe DNA was hybrfdized with filter lifts at 42OC 
in a solution containing 20% formarnide, 10x DenhardY solution, 
5 x SSPE, 0.5% SDS, and 100 @ml salmon sperm DNA. After hybrid- 
ization (18 hr), filters were washed twice at 42OC in a 2 x SSPE, 0.5% 
SDS, and twice at 42OC in 2 x SSPE. Roughly equivalent numbers 
of clones encoding IL-4 Stat and hStat5 were recovered. A 3.8 Kb 
hStat5 cDNA done was sequenced on bcth DNA strands using an 
Applied BiNsystems automated DNA sequencer. 
Northern Blotting 
RNA blot hybridization with a uniformly labeled DNA probe prepared 
from the hStat5 cDNA clone and multiple tissue Northern blot mem- 
branes (Clone-Tech) were used. The probe DNA fragment corre- 
sponded to the region of the hStat5 cDNA that encodes the amino 
terminal segment of the protein (excluding the putattve SH3 and SH2 
domains). Probe labeling, hybridization, and membrane washing were 
performed as described (Sambrook et al., 1989). 
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